| Literature DB >> 27837106 |
Tianyu He1,2, Egidio Brocca-Cofano1,2, Benjamin B Policicchio1,3, Ranjit Sivanandham1,2, Rajeev Gautam4, Kevin D Raehtz1,5, Cuiling Xu1,5, Ivona Pandrea1,2,3, Cristian Apetrei6,3,5.
Abstract
T regulatory cells (Tregs) are critical in shaping the latent HIV/SIV reservoir, as they are preferentially infected, reverse CD4+ T cell activation status, and suppress CTL responses. To reactivate latent virus and boost cell-mediated immune responses, we performed in vivo Treg depletion with Ontak (denileukin diftitox) in two SIVsab-infected controller macaques. Ontak induced significant (>75%) Treg depletion and major CD4+ T cell activation, and only minimally depleted CD8+ T cells. The overall ability of Tregs to control immune responses was significantly impaired despite their incomplete depletion, resulting in both reactivation of latent virus (virus rebound to 103 viral RNA copies/ml plasma in the absence of antiretroviral therapy) and a significant boost of SIV-specific CD8+ T cell frequency, with rapid clearance of reactivated virus. As none of the latency-reversing agents in development have such dual activity, our strategy holds great promise for cure research.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27837106 PMCID: PMC5441309 DOI: 10.4049/jimmunol.1601539
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422